Vysnova Partners, Inc. is thrilled to announce the award of a significant Research Mission Support Services Contract with the National Geospatial-Intelligence Agency (NGA). The contract is valued at $93M and spans over a period of one year with an option for four additional years.
Under the SABER II program, Vysnova continues to support NAMRU-2 to understand and combat infectious diseases and vector-born illnesses including Malaria, Dengue, Chikungunya, Rickettsia as well as the burden and distribution of Swine Flu, Bird Flu, SARS-CoV-2, MERS-CoV and other emerging infectious diseases in Southeast.
Vysnova’s Team Member Spotlight is on Kimberly Lores. Kimberly is an Implementation Specialist.
  Vysnova's Team Member Spotlight is on Mary Quinn! Mary is a Business Development Assistant. She helps with the responses to RFIs/SS. Mary also works with the business development team to gather information from partners to create…
In June 2022, Naval Medical Logistics Command (NMLC) issued a no-cost extension for an existing Task Order under the SABER II program.
Marketing automation software is playing an unexpected role in the fight against COVID-19...Before the start of the COVID-19 pandemic, Derek Kuprianov worked as a digital marketer for a media channel, using marketing automation software to improve the company’s approach to customer engagement and retention. In March 2021, he saw an opportunity he couldn’t pass up—a chance to work with Vysnova Partners, which would eventually be the central coordinating body of a complex study designed to produce real-time data about the virus and its spread across the southeastern United States.
Vysnova will support NAMRU-2 (Naval Medical Research Unit Two) to identify and characterize bacterial causes of hospital-acquired and wound infections among military and civilian populations in South East Asia...
pozomy-federal-contract
Vysnova is excited to announce continued partnership for its joint venture Pozomy Federal, as a mentor to Capitol Advisors on Technology. Pozomy’s first award entered the second year supporting Health and Human Services (HHS) Office of Acquisition in restructuring of the HHSAR, HHSAR supplement, the Acquisition Workforce Policy that supports the contracting enterprise.
Vysnova will support NAMRU-2 to fulfill the goals and objectives of the research project “Deployment of a Highly Multiplexed Sequencing Based Human Disease Panel for Novel Pathogen Detection.”